Tickers

Feed
Show
Sort
  • Latest 10-QQ3 FY2026Positive ·

    Pro-model iPhones and Services drove growth; product mix and tariff refunds lifted margins as Siri AI investment raised R&D.

    • Revenue$109.4BYoY +16.4%
    • Net income$29.8BYoY +27.1%
  • Latest 8-KNegativeEarningsGuidance loweredImpairment / charge ·

    Acquired IPR&D and milestone expenses lower Q3 and FY2026 adjusted EPS guidance.

  • Latest 10-QQ2 FY2026Positive ·

    International expansion fueled booking growth; reserve now, pay later increased cancellations and delayed collections.

    • Revenue$3.6BYoY +16.5%
    • Net income$816.0MYoY +27.1%
  • Latest 8-KNegativeImpairment / chargeLegal / investigation ·

    Preterm infant formula settlements resolve Gill and additional claims after the verdict was upheld on appeal; other lawsuits remain pending.

  • Latest 424B4final IPO prospectusMixedAccounting issueCustomer concentrationControlled company ·

    Builds data-center power and modular infrastructure; Olympus retains 85% of voting power after the offering.

  • Latest 8-KPositiveEarningsNew guidance ·

    Growth across Accenture’s markets, industries and work types beat revenue guidance; FY2027 outlook targets further margin expansion.

  • Latest 10-QQ3 FY2026Positive ·

    Semrush broadens AI marketing workflows, while rising AI computing and selling costs squeeze margins.

    • Revenue$6.8BYoY +12.9%
    • Net income$1.8BYoY +3.1%
  • Latest 424B4final IPO prospectusAccounting issueCustomer concentrationControlled company ·

    Japanese earned-wage-access platform FUKUPE depends on one customer for 93.6% of FY2026 revenue

  • Latest 8-KDebt financing ·

    Issued $3.0B of unsecured senior notes across four tranches maturing in 2029–2036.

  • Latest 10-KFY2026Positive ·

    Pricing and retention lifted Employer Services earnings, while higher insurance and selling costs squeezed PEO profitability.

    • Revenue$21.9BYoY +6.7%
    • Net income$4.4BYoY +8.2%
  • Latest 424B4final IPO prospectusPositivePre-revenue ·

    Develops siRNA drugs for hereditary angioedema and other diseases; $446M all-primary raise funds clinical development

  • Latest 8-KLeadership change ·

    Nuclear development president Alicia Knapp departed involuntarily; severance is conditional on signing a release and other agreements.

  • Latest 8-KPositiveDeal pending ·

    Public Utilities Commission of Ohio approves merger; closing still requires additional regulatory approvals and customary conditions.

  • Latest 8-KLeadership change ·

    Qualcomm CFO and COO Akash Palkhiwala joins Applied Materials’ board and Audit Committee.

  • Latest 8-KDeal pending ·

    All-stock acquisition of World Labs Technologies ties dilution to AMD’s pre-closing share price.

  • Latest 10-QQ2 FY2026Mixed ·

    Repatha, EVENITY and TEZSPIRE gains drove growth as biosimilars eroded Prolia and XGEVA sales.

    • Revenue$10.1BYoY +9.5%
    • Net income$2.4BYoY +65.9%
  • Latest S-1/Aamended IPO prospectusMixedBankruptcy / going concernAccounting issueCustomer concentration ·

    Makes specialty metal powders for defense and aerospace; H1 2026 revenue grew 507% Y/Y, but gross margins stayed negative.

  • Latest 8-KLeadership change ·

    Kristen M. Ludgate joins the board and Compensation and Human Capital Committee, bringing senior people leadership experience at HP and 3M.

  • Latest 8-KDebt financing ·

    GBP notes offering completed across four maturities spanning 2029–2045.

  • Latest 10-QQ2 FY2026Positive ·

    AI infrastructure expansion drives switching and routing demand, while large-customer discounts squeeze gross margins.

    • Revenue$3.0BYoY +37.7%
    • Net income$1.2BYoY +36.5%
  • Latest 10-QQ3 FY2026RestructuringImpairment / charge ·

    Inadequate returns and slow market development drove Louisiana and Casa Grande hydrogen exits, overwhelming stronger industrial-gas earnings.

    • Revenue$3.2BYoY +4.6%
    • Net income−$1.4Bvs $713.8M year ago
  • Latest 8-KLeadership change ·

    Ryan Fisher will lead Harsh Environment Solutions as Luc Walter moves to SVP, Strategic Programs.

  • Latest 10-QQ1 FY2027 ·

    Polaris Forge 1 begins generating rent, but tenant fit-outs and GPU resale inflate revenue growth as financing costs deepen losses.

    • Revenue$341.9MYoY +322.4%
    • Net income−$235.5MYoY −1291.6%
  • Latest 424B4final IPO prospectusBankruptcy / going concernAccounting issueCEO/CFO change ·

    Develops Oxnimbi, a once-nightly sleep apnea pill; $192M all-primary raise funds regulatory work and launch if approved.

  • Latest 8-KEarnings ·

    Athene’s pooled vehicle trailed other alternative investments in preliminary return estimates; final results may differ materially.

  • Latest 10-QQ2 FY2026Positive ·

    Stronger monetization drove AppLovin Ads growth despite fewer installations after the Apps Business sale.

    • Revenue$1.9BYoY +52.8%
    • Net income$1.3BYoY +54.5%
  • Latest 8-KDebt financing ·

    Unsecured 2033 notes are earmarked for credit-facility repayment; a swap converts their fixed coupon to floating-rate payments.

  • Latest 8-KPositiveContract / partnership ·

    First Phase 3-specific DoW funding backs AP-SA02’s superiority study in complicated Staphylococcus aureus bacteremia.

  • Latest 424B4final IPO prospectusPositivePre-revenue ·

    Develops immune-disease biologics using ATTOBODY; $289M all-primary raise backs clinical validation of itch treatment ATTO-1310.

  • Latest 10-QQ3 FY2026Positive ·

    Custom AI accelerators and networking power growth; AI deployment financing adds credit exposure

    • Revenue$29.6BYoY +85.5%
    • Net income$13.1BYoY +216.1%
  • Latest 8-KNegativeImpairment / chargeLegal / investigation ·

    Fed and OCC consent orders resolve financial-crimes compliance reviews; AENB’s penalty leaves FY2026 guidance unchanged.

  • Latest 8-KDebt financing ·

    364-day revolver renewed and two five-year lines extended, adding a $5.0B minimum-liquidity covenant across all three.

  • Latest 10-QQ2 FY2026Positive ·

    Equities trading and investment banking drove earnings growth, while balance-sheet expansion and shareholder payouts tightened capital headroom.

    • Net revenue$31.6BYoY +15.0%
    • Net income$9.1BYoY +26.6%
  • Latest 8-KPositive ·

    Oaktree closed its inaugural Asset-Backed Finance Fund at target, backed by global institutions including U.S. public pensions and sovereign wealth funds.

  • Latest 10-QQ2 FY2026Positive ·

    AI data-center demand and manufacturing efficiencies drove a swing to operating profit; Oracle incentives add dilution and future revenue deductions.

    • Revenue$1.1BYoY +165.5%
    • Net income$196.3Mvs −$42.6M year ago
  • Latest 10-QQ2 FY2026 ·

    Currency gains and lower interest costs drove the GAAP earnings surge as the Middle East conflict slowed room-night growth.

    • Revenue$7.4BYoY +8.1%
    • Net income—
  • Latest 10-QQ2 FY2026PositiveLegal / investigation ·

    ETF inflows and market appreciation lift fees, while HPS private credit and Preqin data broaden revenue sources.

    • Revenue$7.1BYoY +30.6%
    • Net income$1.9BYoY +20.2%
  • Latest 424B4final IPO prospectusBankruptcy / going concernPre-revenue ·

    Develops small-molecule cancer drugs; $150M all-primary raise funds trials led by BH-30643 for treatment-resistant lung cancer.

  • Latest S-1/Aamended IPO prospectusCustomer concentrationControlled companyProceeds to insiders or debt ·

    California homeowners-insurance underwriter earns commissions; offering proceeds go entirely to existing holders

  • Latest 10-QQ2 FY2026Impairment / charge ·

    Eliquis growth and lower U.S. rebates offset Revlimid’s generic erosion; rebate cash outflows weighed on H1 cash flow.

    • Revenue$13.0BYoY +5.7%
    • Net income$3.3BYoY +153.2%
  • Latest 8-KGovernance change ·

    All Series F preferred shares redeemed; related charter provisions eliminated.

  • Latest 8-KPositiveEarnings ·

    Investment gains and the prior-year Kraft Heinz impairment drove the GAAP earnings surge; BNSF and energy lifted operating earnings.

  • Latest 8-KDividend ·

    Board declares quarterly cash dividend payable Oct. 7, 2026 to shareholders of record Sept. 21

  • Latest 424B4final IPO prospectusPositiveImpairment / chargePre-revenueRelated-party dependence ·

    Develops BHB-1893, an oral cardiac myosin inhibitor for hypertrophic cardiomyopathy; $383M all-primary raise funds Phase 3 trials.

  • Latest 8-KLeadership change ·

    Joe Fitzgerald becomes COO as new Interventional Therapies, Rhythm Solutions and MedSurg segments aim to speed decisions and support growth.

  • Latest 8-KNew guidancePreliminary results ·

    Realized performance revenues dominate Blackstone’s preliminary realization estimate, which includes expected quarter-end incentive fees and investment income.

  • Latest 8-K ·

    NYSE-registered securities include Series II preferred depositary shares, trust preferred securities and Citigroup-guaranteed floating-rate notes.

  • Latest 8-KShareholder vote ·

    Stockholders elected three Class II directors, backed executive pay and ratified Frost, PLLC as fiscal 2027 auditor.

  • Latest 8-KClinical / regulatory decision ·

    FDA extends Deramiocel review to assess new HOPE-3 data; Capricor seeks an indication focused on upper limb function.

  • Latest 8-KDebt financing ·

    Replaces the 364-day revolver and extends three- and five-year unsecured credit facilities for general corporate purposes.

  • Latest 10-QQ2 FY2026Positive ·

    Lower catastrophe losses versus the California wildfire-hit prior year lift H1 earnings; underlying underwriting is broadly unchanged.

    • Total investment income—
    • Net income$2.9BYoY −3.8%
  • Latest 10-QQ2 FY2026PositiveCybersecurity incident ·

    China delivery recovery fueled growth; Hexagon expands beyond chip design, but acquisition costs exceed added revenue.

    • Revenue$1.6BYoY +24.2%
    • Net income$367.1MYoY +129.3%
  • Latest 10-QQ2 FY2026Mixed ·

    Calpine added generation and retail scale, but higher costs, acquisition charges and hedge volatility squeezed Q2 profitability.

    • Revenue$7.5BYoY +23.0%
    • Net income$513.0MYoY −38.9%
  • Latest 8-KLeadership change ·

    Donna F. Zarcone will retire from Cigna’s board effective Dec. 31, 2026.

  • Latest 8-KDividend ·

    Common dividend held steady for Q3, in line with Chimera’s plan to maintain the quarterly payout throughout 2026.

  • Latest 10-QQ2 FY2026MixedRestructuring ·

    Productivity savings lift margins, but restructuring and brand spending weigh on GAAP earnings as U.S. toothpaste sales and Hill’s volumes weaken.

    • Revenue$5.4BYoY +4.9%
    • Net income$693.0MYoY −6.7%
  • Latest 10-QQ2 FY2026MixedRestructuring ·

    NBCUniversal and Sky spin-off plans refocus the business on connectivity as customer losses and pricing pressure erode broadband economics.

    • Revenue$29.9BYoY −1.2%
    • Net income$3.5BYoY −68.3%
  • Latest 8-KGovernance change ·

    Eliminated Series G non-voting convertible preferred stock provisions from the certificate of incorporation.

  • Latest 10-QQ2 FY2026Restructuring ·

    Data-center demand powered Power Systems growth, offsetting weaker Engine and Components profitability.

    • Revenue$9.5BYoY +9.4%
    • Net income$932.0MYoY +4.7%
  • Latest 8-KDebt financing ·

    Closed a euro-denominated fixed-to-floating senior note offering with 2032 and 2037 maturities, adding senior debt obligations.

  • Latest 8-KExecutive pay ·

    Special performance-stock awards for James Anderson and four executives target retention, with payouts tied to four-year share-price and relative-return hurdles.

  • Latest 8-KLeadership change ·

    Chief Accounting Officer Jennifer Jones plans to retire; Coinbase has begun a successor search, with Jones staying until a replacement takes over.

  • Latest 8-KInvestor update ·

    Oct. 22 earnings release set for after market close; investor call includes a management update and live Q&A.

  • Latest 8-KCEO/CFO changeLeadership changeExecutive pay ·

    Andy O’Brien succeeds Ryan Lance as CEO; Lance becomes Executive Chair and Konnie Haynes-Welsh becomes CFO.

  • Latest 10-KFY2026Positive ·

    Membership growth and Executive upgrades lift recurring fees as management accelerates warehouse expansion.

    • Revenue$303.2BYoY +10.1%
    • Net income$9.2BYoY +13.9%
  • Latest 8-KDebt financing ·

    Canadian dollar notes guaranteed by CPKC will primarily refinance Canadian Pacific Railway's outstanding debt.

  • Latest 8-KPositiveNew guidanceBuyback ·

    AI adoption and product expansion underpin FY30 growth targets that include Informatica and other announced M&A.

  • Latest 10-QQ2 FY2027PositiveAccounting issue ·

    Falcon Flex and module expansion drove stronger demand; longer commission amortization helped narrow operating losses.

    • Revenue$1.5BYoY +25.8%
    • Net income$5.3Mvs −$70.2M year ago
  • Latest 8-KLeadership change ·

    Cognite CEO Girish D. Rishi joins the board as an independent director.

  • Latest 424B4final IPO prospectusMixedControlled companyProceeds to insiders or debt ·

    Sells data-center space, power and connectivity; nearly all of the $1.05B raise repays debt, with Brookfield retaining control

  • Latest 10-QQ2 FY2026Positive ·

    Intermodal customer wins, new services and cost efficiencies drive profitable growth, but delivery performance deteriorates.

    • Revenue$3.9BYoY +10.1%
    • Net income$1.0BYoY +20.9%
  • Latest 10-QQ1 FY2027Positive ·

    Cross-selling and pricing fuel growth as First Aid and Safety outpaces uniforms; productivity lifts margins despite UniFirst deal costs.

    • Revenue$3.0BYoY +10.9%
    • Net income$551.7MYoY +12.3%
  • Latest 8-KLeadership change ·

    Separation triggers board and officer departures; Luke Kissam takes over as CEO and director, with Jeff Rudolph as CFO.

  • Latest S-1/Aamended IPO prospectusPre-revenueCustomer concentration ·

    RNA interference drug developer seeks $165M–$185M gross to fund CITY-FXI trials and early-stage pipeline development

  • Latest 8-KDebt financing ·

    New senior secured term loan will refinance 2030 secured notes and extend debt maturity to 2033.

  • Latest 8-KLeadership change ·

    Larry Robbins resigns from the Board; JPMorgan Chase data & analytics chief Teresa Heitsenrether appointed as an independent director

  • Latest 8-KNegativeImpairment / chargeDeal pendingContract / partnership ·

    Planned Hess Midstream stake and DJ Basin asset transfer brings revised Bakken contracts expected to halve unit midstream costs.

  • Latest 8-KGovernance change ·

    Reincorporation from Delaware to Nevada changes governing law and certain stockholder rights under a new charter and bylaws.

  • Latest 10-QQ2 FY2026Mixed ·

    Broader observability and security adoption fuels expansion; the largest customer’s Q3 usage reduction threatens growth.

    • Revenue$1.1BYoY +35.6%
    • Net income$44.6MYoY +1583.3%
  • Latest 10-QQ3 FY2026Legal / investigation ·

    Small Agriculture & Turf and Construction & Forestry gains drove recovery, while Production & Precision Agriculture kept contracting.

    • Revenue$12.6BYoY +4.9%
    • Net income$1.4BYoY +7.0%
  • Latest 8-KDebt financing ·

    Dell International and EMC completed a senior unsecured note offering, adding fixed-rate debt backed by parent guarantees.

  • Latest 8-KCEO/CFO changeGuidance reaffirmedExecutive pay ·

    Julie Sawyer Montgomery succeeds Rainer Blair as CEO; Blair stays on to support the transition through March 2027.

  • Latest 10-QQ3 FY2026RestructuringImpairment / charge ·

    Higher parks spending, new cruise capacity and streaming gains lifted profit, while escalating sports-rights costs squeezed Sports margins.

    • Revenue$25.2BYoY +6.8%
    • Net income$2.6BYoY −49.9%
  • Latest 8-KDebt financing ·

    Digital Euro Finco issued euro-denominated green bonds to finance or refinance eligible green projects.

  • Latest 8-KLeadership change ·

    Joyce Mullen joins the board as an independent director, serving on the Audit and Operations and Nuclear Oversight committees.

  • Latest 10-QQ2 FY2026Restructuring ·

    CoolIT acquisition adds data-center liquid cooling, while higher capex and acquisition financing increase cash demands.

    • Revenue$4.4BYoY +9.7%
    • Net income$534.9MYoY +2.0%
  • Latest 8-KGuidance reaffirmed ·

    Officers expect to reaffirm FY2026 earnings and benefit expense ratio outlook in investor meetings; adjusted EPS excludes net unfavorable items.

  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueCustomer concentration ·

    Sells catheter-delivered devices to close holes in the heart; IPO triggers a $7M technology license outside its core business

  • Latest 10-QQ3 FY2026PositiveRestructuring ·

    Test & Measurement’s turnaround helped Software & Systems lead growth; tariff refunds drove most gross-margin gains.

    • Revenue$4.9BYoY +7.0%
    • Net income$718.0MYoY +22.5%
  • Latest 8-KEquity raise ·

    Bought-deal common share offering closed with underwriters fully exercising the over-allotment option.

  • Latest S-1/Aamended IPO prospectusPositiveAccounting issueControlled company ·

    Property-management software and payment processing; Silver Lake retains majority voting control.

  • Latest 8-KEarningsGuidance raised ·

    Higher crude prices amid the Middle East conflict drove an increase in Q3 current tax expense guidance.

  • Latest 10-QQ2 FY2026Positive ·

    Frac 14 and Neches River export expansion lifted NGL margins, while commodity marketing inflated revenue growth.

    • Revenue$18.3BYoY +60.8%
    • Net income$1.8BYoY +28.2%
  • Latest 8-KDebt financing ·

    Cross-currency swaps convert the subsidiary’s new senior-note principal to euros at an effective interest rate of ≈3.95%.

  • Latest 8-KListing notice ·

    Approved voluntary NYSE withdrawal sets up a move to TXSE for common and Series I preferred units, with tickers unchanged.

  • Latest 8-KLeadership change ·

    Andrea Trabacchin takes over as principal accounting officer as Adam Wadecki moves to a non-executive Electrical finance role.

  • Latest 424B4final IPO prospectusMixedBankruptcy / going concernPre-revenue ·

    Develops antibodies to remove disease-driving immune cells; $350M all-primary raise funds ipsoprubart’s registrational trials

  • Latest 8-KEarningsGuidance ·

    ≈60,000 oz of refined gold sales shift to Q4, raising expected copper cash costs above July estimates; Grasberg ramp-up stays on track

  • Latest 8-KShareholder vote ·

    Outside-director equity awards increased; stockholders backed executive pay and rejected an independent FedEx board chair.

  • Latest S-1/Aamended IPO prospectusMixedBankruptcy / going concernControlled companyRelated-party dependence ·

    OK.de webmail ads and referral services; Jensen- and Dartsch-controlled holders retain 72% of post-offering votes.

  • Latest 424B4final IPO prospectusMixedBankruptcy / going concernCustomer concentrationControlled company ·

    Makes copper foil for batteries and electronics; chairman Guanran Wang retains 51.3% control after the offering.

  • Latest 10-QQ2 FY2026Positive ·

    Secure-networking upgrades and pricing fueled hardware growth; expense discipline more than offset lower-margin product mix.

    • Revenue$2.0BYoY +25.6%
    • Net income$606.3MYoY +37.8%
  • Latest 8-KCEO/CFO change ·

    President Danny Deep becomes CEO on Jan. 1, 2027; Phebe Novakovic transitions to Executive Chairman.

  • Latest 8-KLeadership change ·

    Wes Bush became independent Lead Director while Tom Horton stayed on the Board; Judson Althoff joined the Audit Committee.

  • Latest 8-KCEO/CFO change ·

    Claire McDonough to succeed Kenneth Parks as CFO on Jan. 1, 2027 as he moves to a CEO advisory role ahead of retirement

  • Latest 10-QQ2 FY2026Impairment / charge ·

    Acquisition charges and the EVOKE-03 failure overwhelmed growth in Biktarvy and Descovy, driving a GAAP loss.

    • Revenue$7.8BYoY +10.2%
    • Net income−$10.5Bvs $2.0B year ago
  • Latest 8-KEquity raise ·

    Established an at-the-market equity program with Goldman Sachs to fund general corporate purposes through share sales over time.

  • Latest 8-KDebt financing ·

    Supplier-inventory financing aims to secure critical vehicle-production inventory during disruptions; GM pays as inventory is consumed.

  • Latest 10-QQ2 FY2026Positive ·

    Trading-card growth and store cuts lifted retail profit despite falling sales; the eBay stake concentrated capital in the proposed acquisition target.

    • Revenue$790.2MYoY −18.7%
    • Net income$298.7MYoY +77.2%
  • Latest 8-KDebt financing ·

    Senior notes offering closes, adding fixed- and floating-rate debt with maturities stretching to 2066

  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueCustomer concentration ·

    Political campaign texting platform registers existing shares for resale; proceeds go entirely to selling holders.

  • Latest 8-KGovernance change ·

    Series U preferred stock fully redeemed; charter amended to eliminate its designation.

  • Latest 8-KDebt financing ·

    Commercial paper capacity doubled to $8.0B, with HCA Inc.’s unsecured notes unconditionally guaranteed by HCA Healthcare.

  • Latest 10-QQ2 FY2026 ·

    GMS-led pro distribution expansion drives growth, but acquisition dilution and rising expenses limit profit gains.

    • Revenue$47.9BYoY +5.7%
    • Net income$4.8BYoY +4.7%
  • Latest 10-QQ2 FY2026Positive ·

    Hotel additions and co-branded card licensing fueled fee growth; buybacks outpaced operating cash flow as debt and interest costs rose.

    • Revenue$3.3BYoY +6.5%
    • Net income$482.0MYoY +9.5%
  • Latest S-1/Aamended IPO prospectusNegativeAccounting issueAuditor changeCustomer concentration ·

    Nuclear equipment and spent-fuel supplier pursuing Palisades restart; founder-affiliated holders retain 99% of post-IPO votes.

  • Latest 8-KLeadership change ·

    Billal Hammoud moves to lead Process Technology as Ken West exits; Juan Picon succeeds Hammoud at Building Automation.

  • Latest 10-QQ2 FY2026PositiveRestructuring ·

    Options, equities, event contracts and margin lending offset weaker crypto trading; state challenges put event-contract growth at risk.

    • Revenue$1.3BYoY +32.3%
    • Net income$561.0MYoY +45.3%
  • Latest 8-KPositiveGuidance raisedContract / partnership ·

    AI demand and network modernization drive higher networking growth targets; Juniper cost-synergy goal also rises.

  • Latest 10-QQ2 FY2026Positive ·

    Aerospace engines, spares, gas turbines and pricing lifted margins; fastener acquisitions raised debt.

    • Revenue$2.5BYoY +24.1%
    • Net income$534.0MYoY +31.2%
  • Latest 10-QQ2 FY2026Positive ·

    Rising customer trades lifted commissions; larger balances and securities lending offset lower yields as automation widened pretax margins.

    • Net revenue$1.9BYoY +28.1%
    • Net income$312.0MYoY +39.3%
  • Latest 10-QQ2 FY2026 ·

    Confluent lifted software growth but reduced liquidity; delayed IBM Z deals and weaker Transaction Processing weighed on results.

    • Revenue$17.2BYoY +1.1%
    • Net income$2.2BYoY −1.3%
  • Latest 8-KGovernance change ·

    Charter amendment extends stockholder voting and ownership limits to SBSEFs and expands SEC review of charter changes while ICE controls an SBSEF.

  • Latest 424B4final IPO prospectusBankruptcy / going concernAccounting issuePre-revenue ·

    Brazilian rare-earth explorer targets Itarantim’s entirely inferred resources at a $526M implied IPO valuation.

  • Latest 8-KEquity raise ·

    Stock offering upsized to $20B to support Intel’s capex, working capital and investment-grade rating.

  • Latest 10-KFY2026PositiveRestructuring ·

    QuickBooks pricing and product mix drove more growth than customer gains, while Credit Karma helped offset declining TurboTax federal units.

    • Revenue$21.4BYoY +13.9%
    • Net income$4.6BYoY +18.0%
  • Latest 10-QQ2 FY2026Positive ·

    XACDURO and GIAPREZA growth outweighed declining GSK royalties; investment valuation losses swung GAAP earnings to a loss.

    • Revenue$119.6MYoY +19.3%
    • Net income−$83.4Mvs $63.7M year ago
  • Latest 424B4final IPO prospectusPositiveAccounting issueImpairment / chargeCustomer concentration ·

    Converts former Celsius bitcoin mines into AI infrastructure for sole tenant Nscale; direct listing sells existing holders’ shares

  • Latest 10-KFY2026MixedImpairment / charge ·

    Microsoft and NVIDIA contracts anchor the mining-to-AI pivot, while asset write-downs and infrastructure funding drive losses and dilution.

    • Revenue$707.0MYoY +41.1%
    • Net income−$702.6Mvs $86.9M year ago
  • Latest 8-KGovernance change ·

    Bylaw amendments tighten shareholder nomination rules, requiring proponents to solicit holders of 67% of outstanding shares under universal proxy rules.

  • Latest 8-KDebt financing ·

    Issued notes due 2029 to repay part of its commercial paper borrowings, with remaining proceeds available for general corporate purposes.

  • Latest 8-KLeadership change ·

    Operating-model changes drive a planned transition for Global Commercial and Field Operations president Julie Brandt, who will depart after an advisory role.

  • Latest 424B4final IPO prospectusMixedControlled companyProceeds to insiders or debt ·

    Sandwich-chain franchisor; Blackstone retains 65.2% of post-IPO voting power

  • Latest 8-KLeadership change ·

    Tom Cavanaugh will succeed retiring Jennifer Taubert as Innovative Medicine head and join the Executive Committee.

  • Latest 10-QQ2 FY2026Positive ·

    Visa-share and other equity gains amplified reported earnings; stronger client activity lifted Markets and investment-banking fees.

    • Net revenue$57.3BYoY +27.7%
    • Net income$21.2BYoY +41.2%
  • Latest 10-QQ3 FY2026Positive ·

    AI data centers and high-speed networking accelerate testing demand; orders outpace sales as Spirent broadens network-testing capabilities.

    • Revenue$1.8BYoY +36.5%
    • Net income$397.0MYoY +107.9%
  • Latest 8-KInvestor update ·

    Sale of USI Insurance Services to Aon is the focus of the posted presentation.

  • Latest 10-KFY2026Positive ·

    AI-driven investment in leading-edge chips and advanced packaging expands backlog, while receivables and inventory hold back cash growth.

    • Revenue$13.6BYoY +11.7%
    • Net income$4.8BYoY +18.9%
  • Latest 8-KInvestor update ·

    Wolfe Research Utilities, Midstream & Clean Energy Conference presentation will cover business and affairs, with live and on-demand webcast access.

  • Latest 10-QQ2 FY2026PositiveCybersecurity incidentLegal / investigation ·

    Volume-led growth lifted margins, but Asia Pacific’s affordability push and weaker mix limited revenue and profit gains.

    • Revenue$13.4BYoY +6.7%
    • Net income$4.4BYoY +16.1%
  • Latest S-1IPO prospectusCustomer concentrationControlled company ·

    Utility-scale solar and storage builder has only 15.6% of June 2026 backlog under signed contracts

  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueCustomer concentration ·

    Cold-pressed juice seller seeks expansion funding after FY2025 revenue fell 28.3% Y/Y despite lower production costs.

  • Latest 10-QQ2 FY2026 ·

    Electronics demand and APAC project start-ups drove growth, while inflation, energy-cost pass-through and project mix squeezed margins.

    • Revenue$9.3BYoY +9.3%
    • Net income$1.9BYoY +9.2%
  • Latest 10-KFY2026Positive ·

    AI cloud-transceiver demand outstripped supply, prompting manufacturing expansion backed by NVIDIA's investment.

    • Revenue$3.0BYoY +83.2%
    • Net income−$6.9Bvs $25.9M year ago
  • Latest 10-QQ2 FY2026PositiveImpairment / charge ·

    Mounjaro and Zepbound volume, especially abroad, outweighed lower realized prices; acquisition charges tempered earnings growth.

    • Revenue$23.0BYoY +47.7%
    • Net income$7.1BYoY +25.3%
  • Latest 8-KDebt financing ·

    Replaces expiring 364-day unsecured revolver and extends its five-year credit facility by one year.

  • Latest 8-KLeadership change ·

    Executive appointments across Pro and Home Services, stores and AI aim to clarify accountability and accelerate the Total Home strategy.

  • Latest 8-KLeadership change ·

    Sohail U. Ahmed and Michael R. Cannon will retire from the board effective Nov. 2, 2026.

  • Latest 424B4final IPO prospectusPositiveBankruptcy / going concernAccounting issuePre-revenue ·

    Develops oral Nav1.8 non-opioid pain drugs; $346M all-primary raise backs LTG-001 pivotal trials and LTG-321 chronic-pain studies.

  • Latest 424B4final IPO prospectusMixedAccounting issueControlled companyProceeds to insiders or debt ·

    Defense sensors and mission software supplier; company IPO proceeds chiefly repay lenders rather than fund expansion.

  • Latest 10-QQ2 FY2026PositiveRestructuring ·

    Value-added services outpace payment-network growth; customer incentives and litigation payments weaken cash conversion.

    • Revenue$9.3BYoY +14.1%
    • Net income$4.4BYoY +18.6%
  • Latest 8-KPositiveDebt financing ·

    Multicurrency revolver expanded and extended, with an option to link rates and fees to environmental performance.

  • Latest 8-KPositiveNew guidance ·

    NEXT pairs new chicken and beverage share goals with restaurant modernization and franchisee support to drive growth and efficiency.

  • Latest 8-KPositiveListing noticeGuidance withdrawnDeal pending ·

    Planned minority stake in Option Care Health’s buyout with CD&R supports expansion of specialty therapy access in community care.

  • Latest 10-QQ2 FY2026PositiveRestructuring ·

    Leveraged-finance issuance and data-center financing drove Ratings growth; divestitures and a cloud shift obscured Analytics’ subscription gains.

    • Revenue$2.2BYoY +15.1%
    • Net income$878.0MYoY +51.9%
  • Latest 10-QQ2 FY2026 ·

    Derivative gains lifted GAAP earnings while cocoa costs and chocolate volume declines squeezed Europe’s profitability.

    • Revenue$9.4BYoY +4.1%
    • Net income$1.5BYoY +141.5%
  • Latest 8-K ·

    MiniMed exchange offer corrects guaranteed-delivery deadline from midnight to 5 p.m. NYC time on the second NYSE trading day after notice execution.

  • Latest 8-KDebt financing ·

    Completed an underwritten offering of notes due 2036, adding subsidiary-guaranteed long-term debt.

  • Latest 10-QQ2 FY2026RestructuringImpairment / charge ·

    Higher ad impressions and prices drove Family of Apps growth; AI investment and legal charges squeezed operating margins.

    • Revenue$60.8BYoY +28.0%
    • Net income$15.8BYoY −13.6%
  • Latest 8-KDebt financing ·

    €1.5B senior notes issuance raises funding for general corporate purposes, potentially including debt repayment or refinancing.

  • Latest 8-KLeadership change ·

    Rob Gehring departs to lead Coca-Cola North America; Emelie Tirre takes interim charge of the Americas and Caribbean.

  • Latest 8-KDebt financing ·

    One-year extension keeps Altria’s revolving credit facility available through 10/24/2030; all other terms unchanged.

  • Latest 8-KPositiveDeal completedContract / partnership ·

    Performance Technologies spin-off and merger with Gentherm close; net cash proceeds repay Modine’s credit-facility borrowings

  • Latest 10-QQ2 FY2026Positive ·

    Supply disruptions lifted refining margins despite maintenance-reduced throughput; MPLX is accelerating Permian-to-Gulf Coast expansion.

    • Revenue$52.0BYoY +53.8%
    • Net income$5.1BYoY +322.5%
  • Latest 8-KDividend ·

    Third-quarter cash dividend declared, payable October 15 to stockholders of record September 30

  • Latest 10-QQ2 FY2026RestructuringImpairment / charge ·

    Cidara and Terns acquired-research charges drove a GAAP loss despite growth from Winrevair and Animal Health.

    • Revenue$16.6BYoY +5.1%
    • Net income−$1.3Bvs $4.4B year ago
  • Latest 8-KLeadership change ·

    Juan Andres appointed COO to lead manufacturing for a potential intismeran autogene launch and oncology expansion

  • Latest 10-QQ2 FY2026RestructuringImpairment / charge ·

    Mercer Health and Wealth drive Consulting growth, offsetting softer insurance pricing as lower reinsurance rates weigh on Guy Carpenter.

    • Revenue$7.4BYoY +6.2%
    • Net income$1.3BYoY +4.5%
  • Latest 8-KDividend ·

    Quarterly dividend declared; future payouts depend on the board’s assessment of Marvell’s financial position and needs.

  • Latest 10-QQ2 FY2026Positive ·

    Asia equity activity and stronger dealmaking drove Institutional Securities growth; IPO flows boosted Wealth Management asset gathering.

    • Net revenue$21.3BYoY +27.1%
    • Net income$5.6BYoY +57.7%
  • Latest 8-KGuidance reaffirmed ·

    Reporting shifts to Agents and Infra and Devices and Consumer, recasting history and Q1 segment outlook; total-company guidance reaffirmed.

  • Latest 8-KPositiveBuyback ·

    Buyback authorization expands by $2.0B as the prior allotment nears exhaustion; future purchases remain discretionary.

  • Latest 8-KPositiveImpairment / chargePreliminary resultsEarnings ·

    Bitcoin-related valuation-allowance release cut estimated Q3 deferred tax expense; MSTR share sales funded more bitcoin purchases.

  • Latest 10-KFY2026PositiveLegal / investigation ·

    AI memory scarcity drove DRAM/NAND price surges as capacity shifted to data centers and HBM4 entered volume production.

    • Revenue$133.2BYoY +256.3%
    • Net income$85.0BYoY +895.1%
  • Latest S-1/Aamended IPO prospectusAccounting issueControlled company ·

    Menswear and formalwear rental retailer behind Men’s Wearhouse; offering funds debt repayment after shareholder payouts.

  • Latest 8-KLeadership change ·

    Brian Donnelly’s separation agreement provides severance and accelerated time-based equity in exchange for a claims release and restrictive covenants.

  • Latest S-1/Aamended IPO prospectusMixedCEO/CFO changeControlled company ·

    Massachusetts–Rhode Island community lender BayCoast Bank goes public with its mutual parent retaining 55% voting control.

  • Latest 8-KLegal / investigation ·

    Proposed settlement of suits over alleged political influence would strengthen political-contribution oversight, subject to court approval.

  • Latest 8-KLeadership change ·

    Former BHP CFO Peter David Beaven joins the Board and Audit Committee, bringing global mining and finance experience.

  • Latest 8-KPositiveDebt financing ·

    Convertible notes due 2031 fund general corporate purposes; capped calls offset potential dilution only up to a fixed ceiling.

  • Latest 8-KLeadership change ·

    Anne Sweeney resigned from Netflix’s Board effective 7/26/2026.

  • Latest 10-QQ1 FY2027MixedRestructuring ·

    Shift toward wholesale and full-price digital requires inventory clearance; logistics savings cushion earnings as Greater China and Converse weaken.

    • Revenue$11.2BYoY −4.3%
    • Net income$712.0MYoY −2.1%
  • Latest 8-KExecutive pay ·

    One-time equity award for CEO Kathy Warden ties payout to absolute stock-price performance and continued service.

  • Latest 10-QQ2 FY2026 ·

    Armis and Veza expand the platform into security; acquisition amortization and higher delivery costs squeeze GAAP profitability.

    • Revenue$4.0BYoY +24.0%
    • Net income$298.0MYoY −22.6%
  • Latest 10-QQ2 FY2026 ·

    Fuel surcharges drove most revenue growth; higher fuel costs and Union Pacific merger spending weighed on GAAP earnings.

    • Revenue$3.5BYoY +11.4%
    • Net income$734.0MYoY −4.4%
  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernRestatementAccounting issue ·

    Develops NanO2 to deliver oxygen to hypoxic tissue; offering repairs the balance sheet and funds glioblastoma and respiratory trials.

  • Latest 8-KDeal pending ·

    Hugging Face acquisition would keep its platform open to rival silicon; open-source AI restrictions could limit deal benefits.

  • Latest 8-KLeadership change ·

    CHRO Jacqueline Welch will step down on 1/1/2027, eligible for conditional severance and entitled to payouts under her 2020 performance awards.

  • Latest 424B4final IPO prospectusPositive ·

    Fee-driven homeowners insurer; founder Kenneth Gregg retains 93.9% voting power after the offering

  • Latest 8-KEquity raise ·

    Replaced the prior at-the-market equity agreement with a new program allowing up to $1.0B in gross discretionary stock sales.

  • Latest 8-K ·

    Larry Ellison canceled his 10b5-1 plan to sell Oracle stock.

  • Latest 8-K ·

    Q3 earnings release set for Oct. 28 after 3:30 p.m. CT; results webcast follows Oct. 29 at 10 a.m. CT.

  • Latest S-1/Aamended IPO prospectusPositiveProceeds to insiders or debt ·

    Smart rings pair health tracking with paid memberships; 98.8% of company net proceeds fund taxes on vesting employee awards.

  • Latest 10-KFY2026Positive ·

    CyberArk and Chronosphere acquisitions accelerated growth and broadened the security platform, but their operating losses squeezed profitability.

    • Revenue$11.5BYoY +24.5%
    • Net income$307.0MYoY −72.9%
  • Latest 8-KEarningsGuidance lowered ·

    Core EPS outlook cut despite higher FX and acquisition contribution estimates; management is identifying more structural cost reductions.

  • Latest 10-QQ2 FY2026Impairment / charge ·

    Sigvotatug vedotin’s Phase 3 setback triggered an impairment and GAAP loss; falling COVID-19 sales offset Eliquis and Padcev gains.

    • Revenue$15.0BYoY +2.6%
    • Net income−$248.0Mvs $2.9B year ago
  • Latest 10-KFY2026MixedRestructuring ·

    Tariffs and product investment squeezed margins; planned Thorne acquisition broadens the wellness portfolio.

    • Revenue$87.0BYoY +3.3%
    • Net income$16.0BYoY +0.5%
  • Latest 8-K ·

    Severe U.S. weather contributed to catastrophe losses as underwriting margins narrowed despite premium growth.

  • Latest 8-KDebt financing ·

    Dollar and euro senior notes issued to fund repayment of the 364-day Filtration Group acquisition loan.

  • Latest 8-KEquity raise ·

    Underwriters exercised their option to buy additional Prologis common shares, expanding the completed equity offering.

  • Latest 10-QQ2 FY2026Positive ·

    U.S. commercial acceleration broadens growth beyond government, while revenue growth outpaces delivery costs.

    • Revenue$1.9BYoY +92.8%
    • Net income$1.1BYoY +225.0%
  • Latest 8-KPositiveDividend ·

    Quarterly dividend raised 8.8%, extending annual increases since going public in 2008.

  • Latest 8-K ·

    All Series S preferred depositary shares will be redeemed; holders also receive declared but unpaid dividends.

  • Latest 8-KLeadership change ·

    Refining EVP Richard G. Harbison plans to retire effective Dec. 31, 2026.

  • Latest 8-KLeadership change ·

    Board expansion adds Ellen Rubin, bringing AI, cloud and cybersecurity expertise to the Audit and Safety, Operations and Risk committees.

  • Latest 10-QQ2 FY2026MixedRestructuring ·

    Braintree and Venmo lifted revenue, but branded PayPal weakness and faster-rising transaction costs squeezed margins.

    • Revenue$8.7BYoY +4.8%
    • Net income$1.1BYoY −12.5%
  • Latest 8-KContract / partnershipEquity raise ·

    Amazon received a Qualcomm share warrant, with further vesting tied to commitments, orders and purchases of Qualcomm server products and services.

  • Latest 424B4final IPO prospectusNegativeBankruptcy / going concernAccounting issueCustomer concentration ·

    GPU cloud and crypto hosting provider pivots toward AI infrastructure; shareholders sell through a direct listing

  • Latest 8-KPositiveDeal pendingContract / partnershipDebt financing ·

    Deal to acquire a stake in Sandals and Beaches Resorts expands the business into all-inclusive resorts and aims to support resort growth.

  • Latest 8-KLeadership change ·

    Benjamin Lee is stepping down as Chief Legal Officer and Corporate Secretary; Paul Cappuccio is the expected successor.

  • Latest 424B4final IPO prospectusMixedAccounting issueProceeds to insiders or debt ·

    Premium womenswear brand positioned on sustainability; offering proceeds mainly repay debt following a shareholder dividend.

  • Latest 8-KPositiveEarningsImpairment / chargeLegal / investigation ·

    Sanofi deal adds four new long-acting antibodies and settles Regeneron’s lawsuit over commercialization information and audit rights.

  • Latest S-1IPO prospectusMixedBankruptcy / going concernRestatementAccounting issue ·

    RegenKit platelet-rich plasma kit maker faces an October debt maturity exceeding cash despite MiMedx-led U.S. wound-care growth.

  • Latest 8-KLeadership change ·

    Shelley H. Bransten and Christian B. Johnson join the Board as independent directors and Audit Committee members; Sharon D. Garrett retires.

  • Latest 10-QQ2 FY2026Positive ·

    Collection pricing offset weaker volumes and Environmental Solutions demand; renewable-energy tax benefits lifted earnings despite lower pretax profit.

    • Revenue$4.4BYoY +4.6%
    • Net income$566.1MYoY +2.9%
  • Latest 8-KLeadership change ·

    Jill Albertelli will succeed Shane Eddy as Pratt & Whitney president on Jan. 1, 2027; Eddy will advise through March before retiring.

  • Latest 424B4final IPO prospectusNegativeBankruptcy / going concernControlled companyProceeds to insiders or debt ·

    South Korean wireless fire-detection supplier enters a direct listing after FY2025 revenue fell 72.1% Y/Y as construction projects stalled.

  • Latest S-1/Aamended IPO prospectusNegativeAccounting issueCustomer concentrationControlled company ·

    Power and AI data-center developer faces ≈$178B of backlog-linked construction spending under SoftBank control

  • Latest 8-KNegativeRestructuringGuidance loweredImpairment / charge ·

    Back to Starbucks drives North America coffeehouse closures and a lower FY2026 global net-opening outlook.

  • Latest 10-QQ2 FY2026Positive ·

    Higher metal prices outweigh weaker copper output at Toquepala and Cuajone; new financing backs Tía María construction.

    • Revenue$4.3BYoY +40.6%
    • Net income$1.7BYoY +71.5%
  • Latest 8-KDebt financing ·

    Issued fixed-to-floating-rate senior notes due 2032 and 2037.

  • Latest 424B4final IPO prospectusMixedBankruptcy / going concernCustomer concentration ·

    Develops CRISPR medicines to lower cholesterol; $129M all-primary raise funds STX-1150 trials and pipeline development.

  • Latest 10-QQ2 FY2026MixedRestructuring ·

    Lilly’s Ajax acquisition drove the investment gain behind Q2 profit; management is seeking partners for SGR-1505 and SGR-3515.

    • Revenue$58.9MYoY +7.5%
    • Net income$6.0Mvs −$43.2M year ago
  • Latest S-1IPO prospectusRestatementAccounting issueAuditor change ·

    Tokenizes securities on blockchains; post-merger resale registration covers 92.8% of issued shares.

  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueCustomer concentration ·

    Develops superconducting control chips for quantum computers; commercialized products supplied ≈5% of FY2025 revenue.

  • Latest 10-QQ2 FY2026Positive ·

    Greater Shopify Payments adoption drove growth; slower expense growth lifted operating margins despite a lower-margin mix.

    • Revenue$3.6BYoY +33.7%
    • Net income$1.5BYoY +65.8%
  • Latest 8-KDebt financing ·

    New U.S. dollar and euro term loans replace the 364-day credit facility, with maturities in September 2027.

  • Latest 8-KLeadership change ·

    Jing Ulrich joins the board, bringing JPMorgan Chase investment banking and capital-markets experience to the Audit and Finance Committees.

  • Latest 8-KLeadership change ·

    Shesha Krishnapura joins as an independent director as Judy Lin, chair of the Nominating and Corporate Governance Committee, retires.

  • Latest 8-KEquity raise ·

    At-the-market program allows discretionary Class A share sales through six agents; actual sales will determine proceeds and dilution.

  • Latest 8-KExecutive pay ·

    Annual compensation review adjusts base pay for CTO Alper Ilkbahar and legal chief Bernard Shek, plus Shek’s incentive target.

  • Latest 8-KDebt financing ·

    Upsized zero-coupon convertibles fund capped calls and a partial repurchase of 2027 notes; remaining proceeds are available for buybacks, acquisitions and investments.

  • Latest 8-KBuyback ·

    Initiated an accelerated share buyback with JPMorgan Chase; final share count depends on average repurchase-period pricing less a discount.

  • Latest 424B4final IPO prospectusMixedControlled company ·

    Solar-project developer commercializing solar-powered autonomous mowers; Cywinski founders retain 96.55% of post-IPO voting power.

  • Latest 8-KDebt financing ·

    New Series 2026A and 2026B convertible notes could trigger common-share issuance upon conversion.

  • Latest 8-KDeal completed ·

    Acquisition of Cursor maker Anysphere closes, with equity holders receiving SpaceX Class A shares.

  • Latest 10-QQ2 FY2026 ·

    Taubman consolidation lifted revenue, while acquisition-related depreciation, higher financing costs and investment losses cut earnings.

    • Revenue$1.8BYoY +19.5%
    • Net income$484.0MYoY −13.1%
  • Latest 10-QQ2 FY2026PositiveRestructuring ·

    Strong debt issuance and expanding ETF assets fueled Ratings and Indices growth; Mobility’s separation refocuses the portfolio on financial information.

    • Revenue$4.1BYoY +10.4%
    • Net income$1.2BYoY +13.5%
  • Latest S-1/Aamended IPO prospectusNegativeAccounting issuePre-revenue ·

    Develops continuous-delivery lenalidomide for multiple myeloma; IPO funds trials, but approval requires further capital

  • Latest 424B4final IPO prospectusAccounting issuePre-revenueControlled company ·

    TRISO nuclear fuel maker for advanced reactors is valued at 768× FY2025 revenue

  • Latest 8-KDebt financing ·

    Retired remaining 3.50% exchangeable notes due 2028, paying principal in cash and settling excess exchange obligations in shares.

  • Latest 8-KCEO/CFO changeLeadership change ·

    President and COO Spencer Stiles will succeed Kevin Lobo as CEO in January 2027; Lobo moves to Executive Chair.

  • Latest S-1/Aamended IPO prospectusNegativeCustomer concentration ·

    Sells microphones and on-device AI chips; acquired Knowles operations supplied 97% of FY2025 revenue.

  • Latest 8-KLeadership change ·

    Fazal F. Merchant elected independent director as board expands; joins Audit and Corporate Development and Finance Committees.

  • Latest 8-KLeadership change ·

    William A. Jeffrey will not seek re-election to TE Connectivity’s board at the March 2027 annual meeting.

  • Latest 8-KDebt financing ·

    Established a five-year secured revolver for working capital; qualifying investment-grade ratings release collateral and suspend specified covenants.

  • Latest 10-QQ2 FY2026Positive ·

    Tariff refunds drove most of the profit surge, while returning traffic and Roundel advertising growth supported the sales recovery.

    • Revenue$26.5BYoY +5.3%
    • Net income$1.9BYoY +100.7%
  • Latest 8-KLeadership change ·

    Craig A. Pintoff joins the Board and Audit and Finance Committee as an independent director.

  • Latest 10-QQ2 FY2026PositiveRestructuring ·

    Clario boosted clinical research as acquisitions outpaced organic growth; deal spending and buybacks raised debt.

    • Revenue$12.0BYoY +10.5%
    • Net income$1.7BYoY +7.4%
  • Latest 8-KCEO/CFO changeGuidance reaffirmedExecutive pay ·

    Jessica Uhl named CFO successor to Peter Osvaldik for February 2027; Osvaldik will advise through July 1 to support continuity.

  • Latest 424B4final IPO prospectusPositiveAuditor changeControlled company ·

    Chilean ticketing and event-services provider; chair Yethro Dinamarca Santelices retains 61.7% ownership after the offering

  • Latest 8-KLeadership change ·

    Board expands to nine seats with Anthony Jabbour, former Dun & Bradstreet CEO, joining the Audit and Risk Committees.

  • Latest 8-KEarningsGuidance deferred to the call ·

    Model 3/Y deliveries outpaced production; pricing, costs and FX also shape quarterly financial results.

  • Latest 10-QQ2 FY2026 ·

    Americas commercial HVAC demand drove growth, but inflation and investment costs squeezed margins.

    • Revenue$6.4BYoY +10.6%
    • Net income$925.7MYoY +5.8%
  • Latest 8-K ·

    Shares issuable to Invenra under the February stock purchase agreement are being registered for resale pursuant to registration rights.

  • Latest 8-KPositiveDividend ·

    Planned dividend hike extends TI’s streak to 23 years, reflecting its commitment to return all free cash flow to owners over time.

  • Latest 8-KExecutive pay ·

    CEO Matthew Bromberg’s one-time stock award ties vesting to continued service and sustained stock-price hurdles over five years.

  • Latest 8-KDebt financing ·

    Euro-denominated senior unsecured notes offering closes, with proceeds intended for general corporate purposes

  • Latest 8-KInvestor update ·

    Leaders will discuss strategy, recent results and end-market expectations at the Wells Fargo Healthcare Conference.

  • Latest 10-QQ2 FY2026 ·

    Pricing and fuel surcharges drove growth, but fuel inflation and Norfolk Southern merger costs outweighed productivity gains, squeezing margins.

    • Revenue$6.9BYoY +11.5%
    • Net income$2.0BYoY +6.2%
  • Latest 8-KLeadership changeExecutive pay ·

    New global operating model and leadership changes target profitable growth after completing the Amazon volume glide-down and network reconfiguration.

  • Latest 8-KInvestor update ·

    CEO Matt Flannery and CFO Ted Grace will present at Morgan Stanley’s Laguna Conference on 9/15/2026, with a webcast available.

  • Latest 10-QQ2 FY2026Positive ·

    BTIG and stronger capital-markets activity drove institutional banking growth, while consumer and payments earnings fell.

    • Net revenue$7.7BYoY +10.2%
    • Net income$2.2BYoY +19.9%
  • Latest 8-KDeal completed ·

    Australian Strategic Materials acquisition closes, with holders receiving Energy Fuels equity and cash.

  • Latest 8-K ·

    U.S. litigation escrow funding lowered Class B conversion rates, reducing as-converted shares with the same EPS effect as Class A buybacks.

  • Latest S-1/Aamended IPO prospectusAccounting issueCustomer concentration ·

    Supplies pharmaceutical intermediates from Chinese manufacturers; existing holders retain 98.5% of post-IPO votes

  • Latest 8-KLeadership change ·

    LPL Financial president and CFO Matt Audette joins the board and Audit Committee, adding financial and accounting expertise.

  • Latest 424B4final IPO prospectusPositiveBankruptcy / going concernRestatementAccounting issue ·

    Developing oral mizagliflozin for post-bariatric hypoglycemia; $81.3M gross raise funds Phase 2 trials.

  • Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueControlled company ·

    Connects patients with physicians for medical-cannabis certifications; FY2025 revenue fell 34.9% Y/Y as state restrictions hit consultations

  • Latest 8-KDeal pending ·

    Planned King Environmental Services acquisition would extend fluid management, commissioning and load-testing into EMEA for liquid-cooled data centers.

  • Latest 8-KCEO/CFO change ·

    Jonathan Poole takes over as CFO on Jan. 1, 2027; Charles F. Wagner remains EVP and COO.

  • Latest 8-KLeadership change ·

    Recognize Partners co-founder Charles Phillips joins Verizon’s board.

  • Latest 8-KListing noticeDeal completedDebt financingLeadership change ·

    Paramount Skydance merger closes, converting WBD shares to cash and ending its Nasdaq listing.

  • Latest 8-KDebt financing ·

    Calls 2028 convertible notes for redemption; expects substantially all to convert, with principal paid in cash and any excess in shares.

  • Latest S-1/Aamended IPO prospectusMixedRestructuringImpairment / chargeControlled company ·

    Hair and nail products seller behind OPI and Clairol goes public with KKR retaining majority voting control.

  • Latest 8-KEquity raise ·

    New ATM stock-sale program replaces the prior agreement; lease-amendment shares are registered for separate resale.

  • Latest 8-KLeadership change ·

    Scott E. Powell moves from COO to Chief Risk Officer, effective Jan. 15, 2027.

  • Latest 8-KCEO/CFO changeLeadership change ·

    President John Morris will succeed Jim Fish as CEO on Jan. 4, 2027, as Fish retires and leaves the board.

  • Latest 8-KDebt financing ·

    Completed a four-tranche senior unsecured note issuance with maturities spanning 2029–2056.

  • Latest 10-QQ2 FY2027Positive ·

    Store-fulfilled eCommerce and membership drove growth; tariff refunds boosted margins as price investment continued.

    • Revenue$187.9BYoY +5.9%
    • Net income$6.4BYoY −9.4%
  • Latest 8-KDebt financing ·

    Issued floating-rate notes due 2076 with a full, unconditional guarantee from ExxonMobil Holdings Corporation.

Feedback